Published Date: Oct 2024 | Report ID: MI1112 | 220 Pages
The Asia Pacific Diabetes Care Devices market accounted for USD 11.0 Billion in 2024 and is expected to reach USD 29.9 Billion by 2035, growing at a CAGR of around 9.5% between 2025 and 2035. Asia Pacific Diabetes Care Devices Market includes products used for diabetes management and monitoring, like glucose meters, insulin delivery systems, and continuous glucose monitoring (CGM) devices. This market is fuelled by the rising incidence of diabetes, rising awareness levels towards the disease, and technological developments that lead to better management of the disease. These devices are important in the management of diabetes owing to the increasing trend towards individual control and choice of therapy. The market has benefited from government policies promoting the use of telehealth services and subsequently improving the available diabetes care.
| Parameter | Details |
|---|---|
| Largest Market | China |
| Fastest Growing Market | India |
| Base Year | 2024 |
| Market Size in 2024 | USD 11.0 Billion |
| CAGR (2025-2035) | 9.5% |
| Forecast Years | 2025-2035 |
| Historical Data | 2018-2024 |
| Market Size in 2035 | USD 29.9 Billion |
| Countries Covered | China, Japan, India, Australia, South Korea, Singapore, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, and Others |
| What We Cover | Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PESTLE analysis, value chain analysis, regulatory landscape, pricing analysis by segments and region, company market share analysis, and 10 companies with scope for including additional 15 companies upon request |
To explore in-depth analysis in this report - Request Free Sample Report
The factors that fuel the Asia Pacific diabetes care devices market include increased incidence of diabetes due to changes in lifestyle, poor diet, and increased life expectancy. Innovation in diabetes self-monitoring devices, insulin pens, and the development of artificial pancreas systems are improving diabetes care. Growth in education about diabetes coupled with government incentives aimed at preventive healthcare is driving the market. Trends focusing on telemedicine and digital health solutions for the real-time monitoring of glucose levels simultaneously contribute to the market growth. The data from the IDF reveal that in 2021 Southeast Asia was home to almost 90 million adults with diabetes, indicating the necessity for new care devices in the region.
The Asia-Pacific market for diabetic care devices is driven by several factors. Initially, the region has experienced the prevalence of diabetes as a result of obesity and an overall decrease in physical activity, requiring the use of appropriate management techniques. An increase in clinic and hospital facilities allows patients with diabetes to acquire the needed care services and important devices required to manage diabetes.
Technological development related to smart glucose monitoring systems and delivery devices enhances market growth as they maximize accuracy and ease of use. Moreover, rising government initiatives to increase public awareness and prevent diabetes, along with a growing concern for fitness and wellness worldwide, anticipate market expansion. Investments in research and development play a role, as they provide differentiated products that cater to the demands of different patient groups. These elements work together to improve beneficial conditions for the Asia-Pacific diabetes care devices market.
Numerous constraints impede the expansion and accessibility of the Asia Pacific Diabetes Care Devices Market. This includes the regulation of reimbursement procedures and harms affordability due to the population's restricted access to necessary diabetes self-management devices. Furthermore, different regulations in the country lead to confusion and escalated time to market for the various new technologies. The decline in adoption rates is due to inadequate self-management and a relative lack of awareness of diabetes in various regions of the world.
Economic disparities within the region demonstrate a lack of equality, as individuals with lower socioeconomic positions tend to refuse the utilization of available resources for health devices. Furthermore, issues with the supply chain and poor infrastructure could make it more difficult to provide critical diabetic care products, particularly in rural regions.
The Asia Pacific Diabetes Care Devices Market has significant opportunities as a result of changes in lifestyle and the aging of the population. Interprofessional collaboration between clinicians, the technology industry, and the device industry allows the creation of continuous diabetes care systems that support patient care. Technology advancements such as CGM and smart insulin delivery systems are emerging to fit the current needs for more customized diabetes management. Furthermore, growing healthcare expenditures and the focus on digital health opportunities provide the necessary conditions for partnership. This way, using local information and new technologies, suppliers can address the problem and offer products that patients need beneficial for the market.
The Asia Pacific Diabetes Care Devices Market may have a massive advantage of incorporating telehealth into their diabetes care delivery system in remote monitoring. With the rising incidence of diabetes and the high stakes involved in its management, there is a growing need for products and technologies that augment patient tracking and management. The use of telehealth in support of patients and healthcare is beneficial in the real-time provision of patient data, prompt treatment plans, and preventive measures.
Patients can assess their glucose levels and communicate data easily owing to the widespread use of smartphones and wearable devices encouraging this transition. Moreover, remote consultations can effectively minimize anticipatory gaps in medical services, particularly reaching out to remote areas. Due to changes in rules and regulations, the market has huge growth potential, especially for developers of devices and health providers who can create personalized devices that suit different patients.
“Diabetes management is complex and personal for every individual. By combining technology with a deep understanding of the challenges that people living with diabetes face, we seek to enable them to navigate the daily complexities of diabetes management with confidence. The future of diabetes care lies in personalisation, connectivity, and collaboration for healthcare sustainability,”
Based on the product type, the Asia Pacific Diabetes Care Devices market has been classified into Blood Glucose Monitoring Devices and Treatment Devices. Blood Glucose Monitoring Devices are the most prominent product type segment in the Asia Pacific Diabetes Care Devices Market. This is due to the increased number of people with diabetes in the area and the increased focus on patient self-management. The adoption of these devices is forecast to gain an advantage from developments in continuous glucose monitoring technology and their availability. Further, awareness campaigns and healthcare programs related to the regularity of glucose monitoring are improving their use, making them dominant in the market.
Would you like to review the price list for each section?
Based on the technology, the Asia Pacific Diabetes Care Devices market has been classified into Wearable Devices and Non-Wearable Devices. Wearable Devices are dominant in the Asia-Pacific Diabetes Care Devices Market. Some of these devices include continuous glucose monitoring devices and smart insulin pens that capture real-time data and measure patient involvement. This is due to a rise in diabetes cases and growth in attention towards customization in the delivery of healthcare services. Furthermore, increased understanding and implementation of technologies and connections help these devices become more friendly and useful for diabetes management.
The Asia Pacific Diabetes Care Devices market is increasing, and most of the market predominantly relies on China as a manufacturing base for such devices. Faster growth in the prevalence of diabetes due to urbanization, changed diets, and an aging population, there is a greater need for improved diabetes management.
The Chinese authorities are accelerating the management of programs to enhance the healthcare system and access to diabetes care products to drive market growth. The leading market stakeholders aim to design convenient and technologically sophisticated devices such as continuous glucose monitoring systems and insulin delivery devices. Moreover, cooperation between domestic and foreign companies is improving the product portfolio to address patients’ needs. China in particular is positioned to be a leader in the future pattern of diabetes management, as the number of people with diabetes in Asia-Pacific is rising.
The Asia Pacific diabetes care devices market in the Indian market is steadily growing owing to the increasing incidence of diabetes and improvement in awareness levels. India has a population of over 1.4 billion inhabitants, and the country is now experiencing a spike in diabetes cases. As a result, extensive monitoring instruments such as glucose meters, pumps, and CGMS are required.
Existing healthcare policies, effective diabetes prevention, and control management campaigns launched by the government and other related non-governmental organizations are contributing to the market growth. Furthermore, new technologies such as digital health and mobile applications are improving patients’ involvement and compliance with recommended therapy plans. Therefore, India is emerging on the regional map of diabetes care investment and partnership between players in the health sector.
The Asia Pacific diabetes care devices market is driven by a high growth rate of diabetes, a focus on enhanced technology, and well-developed healthcare facilities in Japan. An aging population and an improved understanding of diabetes and its control necessitate the need for CGM and insulin delivery systems. Important stakeholders are investing capital in R&D to create cutting-edge goods that enhance patient care. Moreover, government activity and reimbursement policies remain supportive of the use of new technologies in diabetes care realization.
Digital health solutions extend the support to personalized treatment strategies, placing Japan in a strategic position. In conclusion, the current consumers’ demand, technological enhancements, and favorable policies are factors leading to market expansion.
The Asia Pacific Diabetes Care Devices Market is highly competitive owing to the increasing number of diabetes patients and growth in healthcare expenditure. Some major players include Terumo Corporation, Arkray, Inc., Nipro Corporation, and Sinocare, Inc., which are focusing on the innovation of glucose monitoring systems and insulin delivery devices. The most recent iteration of I-SENS, Inc.'s CareSens blood glucose monitoring systems, offers higher accuracy and more connectivity possibilities. Bionime Corporation has developed smart glucose meters that have integration systems such as Bluetooth for monitoring data. Sugentech, Inc. has chosen noninvasive glucose monitoring technology, to become the key competitive weapon on the market. The expansion of the network in conjunction with regional players comprising local manufacturers and healthcare providers is intensifying competition within the region.
Asia Pacific Diabetes Care Devices Market, Company Shares Analysis, 2024
To explore in-depth analysis in this report - Request Free Sample Report
By Product Type
By Technology
By Distribution Channel
By End-User
By Region
Asia Pacific
List of Companies:
Explore the comprehensive analysis of the North American Diabetes Care Devices. Discover insights on trends, Product Type, Technology, Distribution Channel, End-User, Country, & leading company profiles.
Explore the comprehensive analysis of the Europe Diabetes Care Devices. Discover insights on trends, Product Type, Technology, Distribution Channel, End-User, Country, & leading company profiles.
Explore the comprehensive analysis of global Diabetes Care Devices. Discover insights on trends, Product Type, Technology, Distribution Channel, End-User, Region, & leading company profiles.
Our analysts are ready to help you immediately.
We have received your request for Asia Pacific Diabetes Care Devices Market research report. We value your interest in our services and are pleased to inform you that our dedicated research specialist will be reaching out to you shortly. If you have any further questions or require additional assistance, feel free to let us know via-